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ABSTRACT 
Gynecological cancer is the fourth most common form of cancer among women. Over the past few decades, the growing 
number of survivors has been forced to cope with the consequences of the disease. Of these consequences, the impact of cancer 
on reproduction has been receiving increasing attention. Research shows that the health care of these women poses challenges 
other than medical ones. Although the inclusion of psychologists in health care teams has been particularly valued, studies 
focusing on the psychological implications of the impact of gynecological cancer on reproduction are scarce. Therefore, the 
first aim of this review is to critically reflect on the psychological implications of infertility, decision-making regarding 
childbirth, and pregnancy in the context of gynecological cancer. The second purpose of this review is to provide practice 
guidelines that account for the specificities and demands of these patients. Our findings suggest that gynecological cancer 
entails specific emotional and decisional challenges regarding reproductive issues, highlighting the importance of specialized 
psychological interventions with patients and their families. Providing emotional support and education about sexual and 
reproductive difficulties, supporting decision-making about fertility preservation and childbirth, promoting adjustment to 
cancer during pregnancy and supporting transition to motherhood are the main areas of intervention suggested. A 
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multidisciplinary treatment approach also seems to be essential, and the role of psychological teams can be particularly 
important because these professionals may enlighten and encourage skills in other health care providers. 
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INTRODUCTION 
Gynecological cancer - encompassing carcinomas of the ovaries, cervix, endometrial tissue, fallopian tubes, vagina and 
vulva [1] - is the fourth most common form of cancer among women [2, 3]. These malignancies can occur at different times of 
a woman’s life cycle, including the reproductive age [1, 4, 5]. 
Since the 1970s, the death rates of women with gynecological cancer have significantly declined. As a result, there has 
been a growing number of survivors who are forced to cope with the consequences of the disease and its treatments [6]. 
Among these consequences, infertility has been receiving a large amount of attention over the past few decades [4]. It is 
estimated that 35% of women undergoing chemotherapy or pelvic radiation during their reproductive years experience 
subsequent infecundity [7]. Therefore, fertility preservation in cancer patients and infertility treatments among survivors have 
been main research topics [8-11]. 
There have also been important changes in the social role of women in the last few decades that have contributed to the 
postponement of childbearing. This has led to an increase in cancer survivors who still want to become pregnant [12-14] and 
also the number of cases diagnosed during pregnancy [1, 3]. Several studies have shown the specific difficulties that this co-
occurrence poses in terms of cancer diagnosis, treatment, and prognosis [1]. 
 Consequently, the interface between gynecological cancer and reproduction has become a current problem, which is 
associated with specific medical and psychosocial challenges [13-19]. The majority of studies conclude that the management 
of reproductive issues in patients - including pregnant ones - and survivors requires a multidisciplinary approach. Although the 
inclusion of psychologists in health care teams has been particularly valued in this field [8, 15, 20-25], studies focusing on the 
psychological implications of the impact of gynecological cancer on reproduction are scarce. As such, psychological 
intervention on reproduction in the context of cancer constitutes a less developed area in women’s health care. 
The aim of this review is to critically reflect on the psychological impact of the interface between gynecological cancer and 
reproductive issues in general, and pregnancy in particular, while providing some guidelines for practice. Specific objectives 
include the following: 1) to identify the psychological implications of the impact of gynecological cancer on the reproductive 
pathway of women in terms of infertility and decision-making regarding childbirth, 2) to analyze the psychological impact of 
gynecological cancer diagnosed during pregnancy, and 3) to critically review psychological interventions in this context. To 
achieve this, a brief literature review on the medical impact of gynecological cancer on women’s reproduction is discussed. 
Next, a critical reflection that focuses on the psychological aspects involved is offered, including the presentation of some 
considerations for practice. 
 
THE MEDICAL IMPACT OF CANCER ON REPRODUCTION 
Gynecological cancer treatment is often quite morbid and may include multiple modalities (e.g., surgery, radiation, and 
chemotherapy). Because the tissues and organs involved are closely connected with a women’s reproductive capacity, the 
disease and its treatments may have an important medical impact on the reproductive pathway. Subsequent fertility capacity 
may be compromised in these women [4, 8, 9, 18], and pregnancies after cancer should receive special medical attention [10]. 
The diagnosis of cancer during pregnancy also poses additional challenges for physicians [1].  
   
Fertility capacity after cancer 
In all types of cancer, particularly in gynecological malignancies, questions concerning subsequent fertility pose additional 
challenges to physicians [8, 25-29]. Surgery, chemotherapy, radiotherapy, or a combination of these is often used to treat 
cancer patients. The consensus is that these procedures may cause loss of ovarian function [8, 9, 18, 30]. Moreover, surgical 
treatment for gynecological cancer may change a women’s reproductive anatomy in a drastic way and can even imply the 
removal of critical parts of their reproductive system, causing permanent infertility [4].  
A few decades ago, this did not prove to be a problem. Most women who had cancer, particularly of the gynecological 
type, had already birthed children. Currently, however, the incidence of cancer in those who still want to become pregnant is 
increasing significantly [13, 14, 18]. As a result, over the past few decades, fertility preservation in cancer patients has received 
considerable attention and been an area of major development.  
3 
 
A significant number of studies, from 1965 to 2001, show great decreases in fertility disadvantages reported by cancer 
survivors compared with the general population [8]. Although the preservation of fertility in young gynecological cancer 
patients still represents a major challenge for oncologists, currently, a cancer diagnosis has quite different implications [8, 10]. 
Increases in early detection of most forms of cancer [5, 18], recent developments in surgical techniques, and the currently 
favored less aggressive management of gynecological cancers have greatly improved the prospects of parenthood after the 
disease [5, 8]. Choriocarcinoma, germ cell ovarian cancer, and early cases of ovarian invasive and cervical cancer are some 
examples of gynecological cancers that presently allow for the possibility of undergoing fertility-saving procedures [10, 31, 
32]. There have also been important technological developments in fertility preservation and infertility treatment. When 
preservation of the reproductive organs is not possible, these procedures provide patients with the option of future pregnancies 
[5, 8, 9]. Surgical and assisted-reproduction innovations, such as embryo, oocyte or ovarian tissue cryopreservation, ovarian 
transposition, ovarian suppression, apoptotic inhibitors, and the construction of artificial gametes, are some of the main 
developments in this field [9]. 
 
Pregnancies after cancer 
Women who have experienced cancer are commonly advised to wait one or two years after successful treatment before 
conception [7, 33, 34]. This recommendation is based on the fact that most cancer recidives occur during this period [34]. 
When comparing survivors who became pregnant with those who did not, research has shown no increase of death rates or 
higher incidence of metastasis. Furthermore, there seems to be no increased risk of congenital anomalies or genetic cancer 
vulnerability in children born to cancer survivors. Exceptions were found in children exposed to chemotherapeutic agents 
during the first trimester of pregnancy and in families with rare inherited cancer syndromes [30, 35-43]. However, pregnancies 
in survivors are considered to be high-risk pregnancies, due to an increased percentage of preterm births, low birth weight 
infants, and perinatal loss. These outcomes are more frequent among young women who experience gynecological cancer and 
subsequent treatments, such as pelvic radiation or uterine exposure to radiotherapy [10, 44-46]. 
 
Cancer during pregnancy 
Approximately 1 per 1000 pregnant women develop cancer during pregnancy [12, 15], with the most frequent types being 
uterine, breast and ovary cancer, melanoma, lymphoma and leukemia [12, 20, 47-53]. Among these, breast cancer is the most 
frequent [53]. Gynecological cancers, such as carcinomas of the uterine cervix, ovary, vulva and fallopian tube also appear, 
with incidences of 0.24 to 0.45 [49, 54], 0.05 [55], 0.005 [56] and 0.005 [49] per 1000 pregnancies, respectively. This 
occurrence has increased over the last thirty years [12].  
When gynecological cancer is diagnosed during pregnancy, there is always a conflict between optimal maternal therapy 
and fetal well-being [1, 15]. The medical challenges that gynecological cancer presents when concomitant with pregnancy lead 
to its being considered an extremely high-risk pregnancy [21]. This clinical condition also involves important theoretical, 
ethical and practice dilemmas. Some inherent challenges are unavoidable for physicians in terms of cancer diagnosis, treatment 
and prognosis. 
Some gynecological cancers are asymptomatic, making them difficult to diagnose [1, 26]. Non-specific symptoms and 
hematological and biochemical abnormalities are frequently attributed to normal features of pregnancy [15] and are thus often 
ignored by both patients and physicians [1, 15, 20, 25]. Additionally, the effect of cancer diagnostic procedures on the well -
being of the fetus has not been studied in great detail, and the conclusions of the few studies available are not completely clear 
regarding this subject [21, 57-62]. Consequently, Singh [15] noted that the diagnostic workup of pregnant women with cancer 
should limit exposure to ionizing radiation, and that only absolutely necessary radiologic workup is justified. The author 
explains that ionizing radiation, whether diagnostic or therapeutic, can be harmful to the fetus depending on the dose and 
gestational age of the fetus. Plain chest X-ray and two-view mammography appear to be safe procedures when appropriate 
radioprotection is used; however, abdominal plain films, radionuclide isotope scans and tomography scans should be avoided. 
For imaging of the brain, liver or bones in the context of clinical suspicion for metastases, magnetic resonance imaging has 
been advocated. Finally, gadolinium should be avoided because evidence exists of its capacity to cross the placenta and to 
cause fetal abnormalities in rats.  
Cancer treatment during pregnancy requires balance between obstetric and oncologic management [21]. The choice of 
treatment is influenced by the need to provide the best care for the mother, while minimizing the risk to the fetus [15]. 
Chemotherapy can be administered after the first trimester but not around the time of delivery [25]. When given in the first 
trimester, chemotherapy can lead to fetal loss, neonatal death, or malformations of the newborn [60]. After this period, the risk 
of fetal anomalies is low [59]. Intrauterine growth restriction is the predominant effect [1, 21]. According to some authors, the 
last dose of chemotherapy should occur at three weeks before delivery [51]. It should not be given after 35 weeks of gestation, 
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because spontaneous delivery may occur [60]. Radiotherapy and hormonal therapy are usually avoided [25], and surgery 
should be carefully considered on an individual basis depending on the type of cancer [1].  
Another crucial question when considering cancer treatment during pregnancy is the initiation time. The possibility of 
delaying the treatment until fetal maturation must be carefully considered and balanced with the potential effects on the 
mother’s health. This complex decision is influenced by factors such as the clinical stage of the tumor, gestational age, mother 
and fetus’s health status and the ethical, cultural, and religious values of the patient [1, 20, 25, 61]. 
According to some authors, termination of pregnancy is not beneficial. This scenario is discussed only if the pregnancy 
postpones the appropriate therapy [25]. Conversely, some authors state that the immunological suppression and high 
concentrations of growth factors during pregnancy can adversely affect cancer outcomes [15].  
As such, the prognosis tends to be worse when compared with that of non-pregnant women with the same conditions [20]. 
It is also possible that this is due to the advanced clinical stages of cancer in these women [20, 24]. However, these conclusions 
are not widely agreed upon [28].  
We have thus far described the medical challenges posed by the three major areas of reproduction related to cancer that 
must be taken into account when considering women’s health care. Next, we will focus on the psychological implications of 
these challenges. In relation to fertility capacity and pregnancies after cancer, our critical reflection will focus on the 
psychological implications of infertility and decision-making about childbirth. Subsequently, the psychological implications of 
the occurrence of cancer during pregnancy will be analyzed. 
 
PSYCHOLOGICAL IMPLICATIONS 
Some authors have discussed the increased risk posed by gynecological cancer to women’s mental health. This impact has 
been mainly considered in the management of sexual issues during and after the disease [4, 6, 63, 64]. However, the literature 
about the psychological challenges resulting from the impact of this type of cancer on women’s reproduction is limited. There 
are few available investigations on how cancer survivors cope with the (im)possibility of having children of their own. 
Specifically, no quantitative research analyzes the way women cope with infertility or with the decision-making process about 
having or not having a child after the disease [8, 23, 33]. Also, very few studies have assessed the psychological impact of a 
diagnosis of maternal cancer during pregnancy [21, 29]. This literature is reviewed in the following subsections.  
 
Cancer-related infertility  
There is a reasonable amount of information about the importance of parenthood for cancer patients and survivors. 
Accordingly, studies show that infertility is one of their major concerns [65, 66]. Studies carried out with cancer patients, 
particularly breast cancer
1
 patients, show that these concerns can determine patients’ treatment decisions [14]. Some studies 
also conclude that most survivors feel healthy enough to be good mothers. Women often believe that their illness experience 
increases the value they place on family closeness and are particularly distressed about infertility if they were childless before 
starting treatment. There is also evidence that patients and survivors are not receiving sufficient information about the causes 
of their difficulty in conception and about the existing options for overcoming or treating it [35, 66]. The attitudes, emotions, 
choices and psychosocial consequences that are involved have received less attention from researchers [33, 66, 68]. Similarly, 
little information is available about specific findings in gynecological cancer patients and survivors [69, 70]. 
Infertility is emotionally painful even as an isolated health problem [71]. In the context of cancer, the ability to conceive 
and raise a normal child appears to be a major issue that influences a woman’s quality of life [22, 72, 73]. Some studies have 
shown that cancer-related infertility is a potential cause of distress [68] and long-term depressive symptoms [74]. 
Repercussions on other aspects of survivors’ lives have also been identified. A perceived loss of opportunity for motherhood 
may be devastating to women’s self-esteem and may be potentially damaging to marital or other intimate relationships [68]. 
To our knowledge, no quantitative research has compared the psychological impact of infertility in survivors and in the 
cancer-free infertile population. However, some authors hypothesize that infertility poses specific psychosocial needs that are 
even more devastating to the survivors than to those without a history of cancer. Among other reasons, they mention that 
women often see infertility as a loss of their femininity and that cancer survivors may already have experienced a deep blow to 
their self-esteem or sense of attractiveness [33, 68, 75]. As survivors often have little information regarding the impact of 
cancer treatments on their reproductive potential, this problem may come as a surprise to most women [11, 68]. On the other 
hand, infertile couples often point out that it is difficult for them to get empathy from family or friends because they have lost a 
                                                          
1
 The psychological impact of breast cancer has been shown to be very similar to that of gynecologic cancers. The intimate relation of these two forms of 
cancer with reproduction and motherhood, as well as their impact on self-esteem, sexual-concept and feminine identity are among the main reasons for these 
similarities [63,67]. For this reason, studies carried out among breast cancer patients and survivors were a privileged resource of information for this paper.  
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potential, rather than an actual, child [76]. In a cancer context, an individual’s right to grieve over infertility may be questioned 
even more [33]. Cancer patients and survivors often feel that their fertility concerns are particularly trivialized. They feel that 
health professionals, friends and family frequently believe they should be grateful to be alive, and not concerned with 
subsequent issues (i.e., reproduction) [9, 11]. On this line, infertility after cancer treatments may cause additional 
psychological stress, feelings of loss of control, depression and low self-esteem [9].  
The specific connection between gynecological cancer and feminine identity can intensify these reactions and impair the 
adjustment to infertility [26, 33, 68]. The gonadal effect of cancer treatments and reproductive system removal are the main 
causes of the survivors’ difficulty to conceive a child. However, other aspects of sexual dysfunction after treatment may also 
negatively influence this capacity in gynecological cancer survivors [8, 23]. Among these women, sexual dysfunction can 
include pain and important changes in the anatomy of the reproductive organs. As a result, this form of cancer often involves 
profound modifications in body image, sexual self-concept, and sexual desire [8, 64]. These health issues significantly impact 
the quality of life and emotional well-being of gynecological cancer survivors and may influence their difficulty to conceive 
and subsequent coping ability [64, 69, 70]. 
 
Decision-making about childbirth after cancer 
Despite the great impact imposed by the difficulty of conceiving a biological child on survivors, this is not the only issue 
involved in deciding whether or not to have children after cancer. As noted by Syse, Kravdal and Tretli [8], psychosocial 
mechanisms contributing to childbirth after cancer have been largely ignored in the literature. There is no specific research on 
gynecological cancers in this field. However, a general framework of reproductive decisions and recent developments about 
general and breast cancer survivors are available. These findings constitute useful guidelines for the comprehension of these 
mechanisms. 
Reproductive decision-making is a highly complex and sensitive process, even among healthy women. As noted by Sherr, 
Barness and Johnson [77], decision-making depends on the pre-existing views of the information recipient, their desires and 
wishes, the way the information is presented, the framing of the data, the relative risks, the associated benefits and the personal 
relevance of these variables. Moreover, the decision to become pregnant is influenced by multiple interacting personal, 
cultural, and social factors [78, 79]. Among these factors are the individual psychosocial and economic situation, the influence 
of partners, family, and friends, and the attitudes and practices of their medical providers [11, 80].  
In 1988, Michaels proposed a behavioral decision-making approach to examine reproductive decisions [11]. According to 
this framework, “a decision about whether to have a child at a certain point in time will be determined by the expected value, 
defined as the degree to which it is perceived to be the optimal way of obtaining desired goals and avoiding undesirable 
outcomes” [11, p. 284]. Thus, motivations appear to be an important construct in the decisional process of conception [81].  
There are both negative and positive motivations associated with the decision to have a child among healthy women. The 
negative motivations most cited include the following: loss of freedom, interference with career development, financial 
considerations, possibility of a defective child, fear of responsibility and immaturity. Positive motivations are often related to 
proof of femininity, fulfillment of the social role as a woman, symbolic immortality, sense of power, and fantasies about the 
self (e.g., having a perfect love, feeling important) [11]. 
These motivations are important determinants in the implementation of the desire to have children. However, other factors 
play an important and direct role. Among them are the occurrence of major life events, the availability of social support and 
several barriers to motherhood [81]. People are generally subjected to a number of biases when making decisions, and this 
process is affected by emotional factors and individual coping strategies [77]. With this in mind, it does not seem unreasonable 
to assume that this decision-making process becomes even more complex in the presence of a serious illness. This often 
constitutes a major life event and may interfere with an individual’s emotional well-being and capacity for decision-making. 
In the particular context of cancer survival, the literature shows some specific negative motivations for childbirth, with 
fears related to the impact of pregnancy on both the woman’s and child’s health among the most cited [11, 35, 66, 68, 82, 83] . 
These concerns may be intensified in the case of gynecological cancer, because of the intimate relationship between the 
involved organs, reproductive capacity, and the unborn child’s well-being. Other negative motivations are associated with 
survivors’ ability to be good and present parents, fears of not living to see their children grow up, having diminished energy to 
cope with the challenges of childrearing, and fears of not being able to be sufficiently resourceful parents [33, 68, 82]. 
Similarly, fears of being unable to support the family or of unpredictable social or psychological implications for themselves 
and their children are also mentioned [35, 83]. In Braun, Hasson-Ohayon, Perry, Kaufman and Uziely’s research [11], breast 
cancer survivors, compared with healthy women, reported more negative motivations toward childbirth due to health concerns. 
Less conservative reasons, such as financial and personal restrictions, fear of responsibility and immaturity, were identified 
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among this population. These findings suggest a possible change in life priorities and attitudes as a result of the cancer 
experience.  
Most studies show the increase of value that is placed on children and family life after experiencing a serious illness [35, 
66, 83]. Some investigations with the breast cancer population reveal that the illness did not negatively influence couples’ 
planning regarding childbirth [11, 35, 83]. Moreover, this desire may be intensified [33, 82]. Most authors suggest that having 
survived cancer leads to new symbolic meanings being attached to having a child, such as being normal and capable of 
producing something beautiful [35, 83]. Research also shows that breast cancer survivors’ partners reported more positive 
motivations related to immortality [11]. In gynecological cancer patients, it is possible that some of these new symbolic 
meanings are even more present, due to the specific threat that the disease represents to sexual functioning, reproductive 
capacity [8, 23], and feminine self-esteem and identity [63].  
 
Cancer during pregnancy 
The psychological implications of cancer occurrence during pregnancy have recently been discussed [21, 22, 29, 84]. There 
is no specific research about the diagnosis of gynecological cancer during this period. However, it is possible to draw some 
considerations regarding the specificity assumed for the impact of this type of cancer. In general, the psychological 
implications of this co-occurrence can be considered according to three broad areas: the meaning of cancer, cancer treatment 
decisions, and transition to motherhood. A critical analysis of the available literature is presented in the next subsections.  
 
The meaning of cancer during pregnancy 
The diagnosis of cancer is a devastating moment for the individual [4, 63]. Emotions such as shock, disbelief, emotional 
turmoil [4, 85], sadness [6], anger, anxiety, and guilt are recurrent in response to this event [4, 6, 63]. The diagnosis may 
interfere with mental and physical abilities and cause severe lifestyle disruptions. Personal, family and social roles, as well as 
the idiosyncratic belief system, are often affected. Cancer threatens fundamental assumptions about a patient’s life, suddenly 
questioning beliefs about self, the world and relationships [86].  
Sometimes, before individuals have had time to work through their feelings of shock and grief, they must begin a treatment 
plan [4]. Most of them are unprepared to deal with the many side effects of medical treatment and its psychological 
consequences. They experience heightened anxiety and depression not only at diagnosis, but also at critical points during the 
disease or treatment [64]. Among gynecological cancer patients, risk factors for maladjustment include treatment 
characteristics, such as the location of surgery [63, 87]. Radiotherapy, multi-modality treatment [26] and the short- and long-
term side effects of treatment also appear to be risk factors [2]. Most studies show specific adverse reactions to physical 
outcomes in this clinical population, and women sometimes interpret them as a mutilation [63]. Consequences, such as intense 
depressive symptoms [88], lower quality of life [26, 29], and problems related to sexuality, body image, health perception, 
physical functioning [87], and intimate relations are the most cited in the literature [29, 64]. 
 As noted by Moorey and Greer [86], and according to Lazarus & Folkman [89], the individual’s adjustment to the disease 
is a result of the interaction between the perception of the stress involved and the coping strategies available. The patterns of 
thought, feelings, and behaviors associated with the cognitive appraisals of stressful events compose the style of adjustment the 
person develops. The way individuals respond to stressful events is determined by the interpretations they make about them 
[89]. Consequently, some authors state that the stress experienced in cancer conditions depends largely on the specific meaning 
that the individual attaches to the disease [63, 86].  
Cancer, in general, often represents an enormous sense of loss. Specifically, it involves loss of autonomy, good health, self-
esteem, relationships, employment, social status [63], fertility [26, 28] and mental integrity [22]. However, the threat posed by 
a cancer diagnosis may be interpreted in several ways by different individuals and under different conditions [63, 86]. 
Regarding gynecological cancers, its specific characteristics should be taken into account in order to understand the threat 
that the disease represents for patients as well as their feelings about themselves as women and about childbearing. The uterus, 
vagina, and ovaries are organs directly connected with the feminine identity [63]. This connection can harm women’s sense of 
self-worth and sexuality, thus affecting their quality of life [4, 87, 90]. Moreover, this impact may be more intense when cancer 
occurs during pregnancy [22, 29, 91]. As this is a moment of women’s life when their female role and disposition to 
motherhood are even more salient, it is necessary that they adapt to profound changes in sexual and reproductive anatomy and 
functioning, which can be extremely difficult and may amplify the physical and psychological impact of the disease. 
A number of authors assume that being diagnosed with cancer during pregnancy constitutes a dramatic event, which may 
have a devastating impact on the patients’ somatic and psychosocial health. Indeed, this co-occurrence combines two life 
events that may cause great stress. In these two opposite biopsychosocial processes, women are concomitantly faced with death 
and life in their own body. It is possible that the threat’s perception and the meaning that women attach to the losses associated 
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with cancer are more accurate [21, 29, 91, 92]. Firstly, the implications of any serious illness that occurs during pregnancy 
results from the traumatic impact of the diagnosis. This is a period when women are somatically and psychologically weaker 
[21, 29]. Additionally, during pregnancy, women expect a new life to be born, which may lead to a cancer diagnosis being seen 
as an even more unexpected event. The confrontation with death is probably more salient in a period when the meaning of life 
is present in all contexts of a woman’s life. The stress perceived and the traumatic impact of the diagnosis can be higher under 
these conditions.  
Secondly, the disease doesn’t interfere exclusively with the lives of women. Cancer during pregnancy also threatens the life 
and well-being of their unborn child. It brings additional awareness to women about the possibility of losing their child. In 
some cases, it may also imply the permanent loss of the possibility of becoming a mother. In addition, this co-occurrence 
reinforces the negative meaning attributed to the loss of some capacities, abilities and opportunities because women’s 
competencies for motherhood are also at risk [22, 29]. 
Thirdly, during pregnancy, women’s patterns of behavior, their place in society and within the family and their own 
identity are in transformation [21]. Therefore, it does not seem unreasonable to hypothesize that the impact of a cancer 
diagnosis may be even greater for the idiosyncratic belief system of these women under these conditions. 
Finally, there is also a great stress perceived in association with cancer management when it occurs during pregnancy. This 
co-occurrence requires a high mobilization of resources and energy to cope with diagnosis and treatment. It occurs at a 
moment when women’s resources to cope with stressful life events may be reduced [22, 29]. It is also possible that women 
perceive the resources of the care system in dealing with cancer during pregnancy as reduced. This can be explained by the 
technical and ethical dilemmas posed by the clinical condition and by the lower agreement about how best to manage it. Thus, 
this reduced individual perception and the care system resources may contribute to appraisal of the available coping strategies 
insufficient. The consequent lowered perception of control can exacerbate emotional distress [93, 94]. These women can also 
neglect getting appropriate assistance [95]. 
 
Cancer treatment decisions during pregnancy 
Cancer treatment requires some decisions that must be shared between the patient and the medical team [96]. This process 
has to be quicker when a pregnancy is involved [22, 97].  
In order to make decisions in the presence of a serious illness during pregnancy, women need information about all the 
medical issues involving both the child’s health and their own. Available options and possible consequences of each are also 
important in their decision-making process. Indeed, information is a basic building block for decision-making [97]. However, 
beyond the necessary and delicate balance between the medical risks and benefits of treatment, other factors need to be 
considered including the following: patients’ life, work responsibilities, family commitments, financial burdens, additional 
inputs from culture, social norms, and spirituality [98-100].  
This process places numerous additional challenges on physicians and patients. Women are characteristically insecure 
about decisions that have to be made in high-risk pregnancies. They become confused and disorganized at a time when vast 
amounts of medical information must be comprehended [62]. In cancer situations, the great emotional impact of the diagnosis 
may significantly reduce patients’ ability to understand the information they are given. There is agreement in the literature 
about the adverse effect that anxiety may have on a person’s ability to process, recall, and comprehend information [97]. 
Additionally, pregnant patients are confronted with suboptimal therapeutic options, none of them being the ideal. They also 
have to make choices in a short period of time, and ambivalence often marks the decision in these cases [22]. Feelings of 
doubt, isolation, helplessness, anger and guilt can also surface [22, 29, 62].  
In some cases, decisions about the continuation of the pregnancy also have to be made, which probably causes even more 
difficulties than the treatment choices. The choice of the type or the time of treatment is often perceived as a shared 
responsibility between physicians and patients. Patients often view this choice as having an indirect effect on their own and 
their fetus’s lives. This is due to all the probabilistic issues involved. On the contrary, although equally shared, couples often 
perceive the decision of continuing or terminating a pregnancy as a direct determination on the life of the fetus or the woman. 
Emotional and moral dilemmas are inevitably inherent to this situation, and feelings of guilt, loss, ambivalence, despair and 
confusion are expectable [22, 29]. 
 
Transition to motherhood during cancer 
Transition to motherhood is a transformational process that demands a woman to redefine herself and accept the pregnancy 
and the psychological stress related to it. The establishment of an attachment to the fetus and the adaptation to a relationship 
with the neonate after parturition are also developmental tasks of this period. It prepares women to adequately and sensitively 
answer their infants’ needs [21, 62, 101, 102].  
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Pregnancy marks the beginning of this elaborated transition. It is usually regarded as a period of great joy and anticipation. 
However, it is also a time of complex interrelated changes in physiologic equilibrium and interpersonal associations [62, 101-
103]. Pregnant women must adapt to an altered physiology, body image, energy level and mood, and changes in interactions 
with parents, spouse, and other significant individuals. Redefining goals with personal meaning is also referred as a central task 
in this period of a woman’s life. The presence of personal fears, uncertainties, expectations, preoccupations, and ambivalent 
feelings of vulnerability, incompetence, loneliness, and loss in terms of autonomy, appearance and occupational identity is to 
be expected [62, 104-106]. As in all important lifecycle events that bring on changes in regular patterns of functioning, 
pregnancy and the transition to motherhood involve stress even in healthy conditions [62, 107, 108]. It may be an experience 
marked by overreactions to minor incidents and over-sensibility and a time of risk to heightened anxiety and depression [109, 
110]. 
The social and psychological implications of a high-risk pregnancy may be even more significant. Intensive testing, lengthy 
hospitalizations, prolonged bed rest at home, illness or disability superimposed on pregnancy, realistic fears for personal safety 
and the life of the unborn child, and a greater risk of being separated from the newborn child pose numerous additional 
challenges. The normal emotional changes in pregnancy may also be intensified. Several studies show higher levels of stress, 
depression and anxiety during these pregnancies [62, 88, 110].  
The diagnosis of cancer during pregnancy may exacerbate this risk for maladjustment, which is already higher in high-risk 
pregnancies. This is due to the severity of this disease, its impact on survival and the invasive and aggressive treatment 
procedures it encompasses. Moreover, in gynecological cancer cases, the body changes during pregnancy may be intensified 
by perceived changes due to the presence of the disease [22, 29]. Women’s adjustment to changes in their body image related 
to pregnancy may be difficult [21, 62]. Additionally, perceptions about giving birth to a child with the eventuality of not being 
alive or healthy enough to take care of it may also bring additional feelings of guilt and sadness [29]. As such, it is crucial to 
recognize that high-risk pregnancies in general, and pregnancies in cancer patients in particular, may be associated with 
additional difficulties, requiring early mental health intervention [62, 110]. 
Some authors state, based on their clinical experience, that the co-occurrence of cancer and pregnancy might also 
contribute to the suspension of other psychological processes involved in the transition to motherhood. Tasks such as 
reorganizing identity, reappraising key relationships, thinking about the viability and normality of the infant, and elaborating 
thoughts, fantasies, and practical preparations for the newborn appear in the literature as being especially difficult in cases of 
cancer during pregnancy [104, 111]. The disinvestment in the unborn child and the inhibition of attachment capacities are 
some consequences of the suspension of these tasks [29].  
However, there is reasonable agreement in the literature about the role of maternal anxiety and depression during 
pregnancy in an increased risk to a fetus’s physical development (e.g., motor activity, intrauterine growth, birth weight, and 
prematurity) and a child’s long-term neurodevelopment [112-117]. For this reason, some authors have called attention to the 
effect that the distress experienced by a pregnant cancer patient may have [22, 118]. The emotional well-being of the future 
mother is also essential during pregnancy to facilitate attachment to the newborn and to effectively develop parenting 
competencies [119, 120]. Besides the suspension of some normative tasks that may facilitate this attachment during pregnancy, 
Wendland [29] states that a maternal illness as serious as cancer may interfere with the establishment of early mother-infant 
interactions at several levels. In addition to the greater risk of prematurity and separation after birth, these women are often in a 
period of great physical and psychological fatigue, and are, thus, less available for these interactions. This may put the children 
of these women at risk for additional emotional difficulties and diminished developmental opportunities. Feelings of guilt often 
appear to be associated with the suspension of these tasks both before and after birth. Some women consider themselves 
egotistical for having to focus their efforts on their disease and not concentrating only on their child. As noted by Elmberger, 
Bolund, and Lützén [121], parents are expected to act as the anchor that nurtures and provides emotional security for their 
children, and the perception of not being able to correspond to this can be disrupting. 
Furthermore, aspects such as sexuality [89], relationships with partners [29, 64], motivations, opportunities, contextual 
constraints and perception of control [86] or mental health [26, 29, 88] are largely influenced by the presence of cancer. These 
aspects influence, in their turn, the quality of the transition to motherhood [101, 102]. Among them, the presence or absence of 
perceived control has been highlighted to have a strong impact on individual adaptation and well-being in situations of stress 
and problem-solving [93, 94, 122]. In a high-risk pregnancy, the sense of control may be clearly impaired, because women’s 
choices regarding pregnancy and childbirth are realistically limited [62]. These women are often confused about what is 
actually happening with their body, may fear having an abnormal child, and may feel a loss of control over the pregnancy. 
Accordingly, Lobel, Yali, Zhu, DeVicent and Meyer [95] mention that optimism is a protective factor against distress in high-
risk pregnancies. Enhanced perceptions of control may account for a portion of this benefit; that is, optimistic women are more 
likely to appraise their pregnancy as controllable. This type of appraisal was associated with lower emotional distress. 
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However, it is also necessary to give cancer patients realistic information about their clinical condition, which may make this 
optimistic approach difficult.  
 
PSYCHOLOGICAL INTERVENTION 
The potential value of health psychology interventions has been emphasized in three main areas: 1) promoting health and 
preventing disease, 2) counseling patients and their families during illness and subsequent treatments and 3) helping physicians 
and other health care professionals to provide the best possible care for the patient and to facilitate medical procedures through 
adequate communication [123, 124]. However, specific contributions for the health care of gynecological cancer patients, in 
terms of reproductive repercussions, are scarcely mentioned in the literature. Nevertheless, the reflections made so far, as well 
as the integrative approach provided by this paper, contribute to important guidelines for practice in this field. This will be 
presented next, according to two major areas of contribution: intervention with patients and families and work with health care 
providers.  
 
Intervention with patients and families 
Prevent and treat sexual and reproductive difficulties among cancer patients and survivors 
Sexual and reproductive issues are among the main concerns raised by cancer patients and survivors [74, 125-128]. It is 
important to take into account the amplified effect that infertility and sexual dysfunction can have on the emotional well-being 
of these women [23, 66, 68, 74]. The provision of counseling based on emotional support, unconditional acceptance and 
recognition and validation of their needs and feelings is crucial. Education about diagnosis, treatment, potential late effects, 
fertility-preserving options and sexual functioning should also become part of their health care. The development of patient 
education materials and individual, couple or group counseling are adequate in this context [5, 23, 64, 66, 68, 129].   
 
Support survivors’ decision-making about childbirth 
 Health professionals should consider the importance of the decision-making process about childbirth for cancer 
survivors. They should be aware of all the concerns, beyond the medical ones, involved in this decision. It is essential that 
health professionals know the positive and negative motivations of childbirth in this clinical population and that they provide 
patients with accurate and adequate information on this topic in order to educate them on the decisions they will have to face 
[11, 35, 83]. As we noted before, some findings suggest the presence of new symbolic and personal meanings to having a 
child. The decision of having a child based only on personal motivations, such as personal gratification, may put the normative 
tasks of transition to motherhood at risk. The complexity of this transition requires that parents decentralize themselves so that 
they are able to invest in personal and relational reorganization [101, 102]. In our opinion, all reproductive decisions that are 
based on the best interests of the child will certainly be protective against those risks and should be supported by appropriate 
psychological interventions. Integrating the partners of cancer survivors appears to be useful for the quality of this intervention. 
The literature also mentions that peer support groups of young survivors may provide an important source of support. In this 
context, women may be given the opportunity to express their fears, hopes and wishes regarding childbirth [11].  
 
Promote adjustment to cancer during pregnancy 
The psychological impact of the diagnosis of cancer during pregnancy is expressed at several levels, requiring 
differentiated and specialized psychological care [15, 21, 22, 29]. Emotional support and counseling are useful at the diagnosis 
stage to avoid the traumatic impact that diagnosis may have. Promoting the ventilation of emotions and the cessation of 
associated intrusive thoughts may contribute to fostering women’s psychological adjustment. Revising life goals and lifestyle 
and activating support networks are also important [22, 130]. Important sources of support include the woman’s partner, peers 
and community. All intervention programs should include areas other than the hospital, such as work, household and 
community [130].  
Integrating family, especially women’s partners, also seems to be beneficial. Sometimes these agents are not able to 
provide adequate emotional and instrumental support. Because they are often greatly affected by the situation, it is necessary to 
value and assess the adjustment difficulties they may be facing [21, 22, 62, 86]. Encouraging open communication and the 
expression of thoughts and feelings about the diagnosis and the clinical situation is important. It is useful to assist partners and 
family members in dealing with patients’ feelings and reactions by listening and responding empathically [21, 62, 86, 130].  
Promoting a sense of control may also be particularly important. This can be implemented through the identification of 
controllable aspects of patients’ clinical situation. Finding possible means of monitoring the mother and the unborn child’s 
clinical conditions as well as learning the possible medical response in emergencies and the percentage of controllability of the 
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medical procedures used may be useful. Involving patients in active self-monitoring and decision-making is also crucial in 
order to develop this sense of control [22, 62].   
Additionally, in extreme cases, decisions about the continuation or termination of the pregnancy may have to be made, and 
these couples require special emotional support. There is also a need for a specialized psychological care and a 
multidisciplinary intervention designed to provide all the information and support they need to comprehend and understand the 
medical data [22, 29, 97].  
 
Promote and support transition to motherhood during cancer 
There is another area of intervention that should be taken into account in the planning of psychological care of women who 
experience cancer during pregnancy: promoting and supporting normative tasks of the transition to motherhood. The 
establishment of an adequate maternal-fetal relationship during pregnancy and after birth has to be stimulated and enhanced. 
However, the suspension of other developmental tasks during pregnancy must be prevented, and increased emotional support 
is needed for a successful transition. It is important to allow the evocation and expression of difficulties, feelings of guilt and 
ambivalence that are usually associated with the cancer occurrence during pregnancy and also to normalize and validate these 
thoughts and feelings [22]. However, health care providers should not forget that a realistic orientation in the transition to 
motherhood seems to predict women’s adjustment. Churchill and Davis [131] suggest that the principles of cognitive therapy 
that are consistent with the development of a broad and realistic orientation may be implemented in prenatal and outreach 
programs as a preventative measure. This orientation requires the consideration of possible positive and negative outcomes of 
the transitional process to motherhood and the development of action plans to manage those situations. 
 
Work with health care providers 
Participate in multidisciplinary teams  
The majority of the studies in this area conclude that the management of these patients requires the collaboration of many 
specialties. This multidisciplinary approach should include physicians, nurses, psychologists, and social workers in order to 
provide better educational, decisional and emotional support practices for the patients [15, 20-25]. 
Specific guidelines on how to cope with cancer during pregnancy are available. According to these guidelines, the decision-
making process when facing cancer treatment choices should receive special attention from multidisciplinary collaborations 
[132]. Because medical, psychological, religious, social and moral standards are involved, multidisciplinary teams should 
provide emotional support to these women and actively involve them in their health care decisions [67, 130]. 
Providing multimodal motherhood education programs in the health services can be especially useful. These programs 
should aim at preventing the disinvestment in the unborn child as well as in other normative tasks of the transition to 
motherhood and the cancer treatments. It can also be important to use routine medical procedures during pregnancy to promote 
the establishment of a mother-infant connection. Touch, guided imagery or ultrasound visualization and childbirth education 
programs can help the patient to build a more concrete image of her unborn child’s development and behavior and promote an 
affective relationship with him [22, 62]. After birth, it is important that time is devoted to the interaction between mothers and 
their infants. If this interaction is not possible, photographs and videos can be used to initiate and maintain the parent-child 
relationship. However, establishing prenatal and postnatal practices that maximize parent-infant interactions and other 
transitional tasks to motherhood can require changes in hospital routines and policies. It is crucial that hospital practices and 
health care team behaviors are consistent with this goal. Only a multidisciplinary approach can make the collaboration of all 
health care providers possible and build the best circumstances to implement them. Moreover, raising the awareness of health 
professionals regarding the importance of these procedures and involving them in implementation can facilitate the adherence 
of patients and increase efficiency [62].  
 
Provide education and skills training to health care providers 
The literature often suggests that health care providers may benefit from information and training on how and when to 
address sexual and fertility issues with their patients [62, 66]. One way to help physicians is by improving their knowledge and 
sensitivity concerning the psychological aspects associated with the medical consequences of gynecological cancer. Health 
care providers need to acknowledge the nuclear role of sexual and reproductive issues in patients’ lives, even while they face a 
life-threatening illness [11]. Improving their communication skills can also be useful in order to improve the quality of patient-
provider communication [66]. 
Cancer during pregnancy also poses additional challenges to health professionals when communicating information about 
and managing the disease. Firstly, breaking bad news, such as a cancer diagnosis, to a pregnant patient is painful and 
challenging; thus, good communication skills are required. The diagnosis should be explained by people skilled in 
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communication with high biomedical and psychological competency [133, 134]. According to Client-Centered Therapy [135], 
founded on Humanistic Psychology, communication should be made in a patient-centered way, so that it is perceived as 
emotional and non-dominant. The term “patient-centered communication” has been used to describe a group of communication 
strategies and behaviors that promote mutuality, shared understandings, and shared decision-making in health care contexts 
[136]. Specifically, encouraging patients to express feelings, name and legitimize them, and convey hope can be adequate 
strategies for cancer situations during pregnancy. It is also important to assess patients’ understanding of their situation and 
their awareness of the prognosis. Providing information about the support services available, documenting it, and offering 
assistance about relaying information to others can also be useful [22, 134, 137-139]. Secondly, helping pregnant cancer 
patients in decisional processes about treatment is also a demanding task to health care providers. This should be a shared 
process [22, 67], and information may be provided gradually, using simple, clear, but not blunt, language [22, 140-143]. It is 
important for women to have time to reflect, rehearse, and change their decisions. This can help them make good decisions and 
also have adjusted reactions when they review their decisions [97]. The role of psychologists can be very important in this 
situation, providing psychoeducation to other health care providers and helping them in the development of adequate 
communication skills for these specific situations. 
 
CONCLUSION 
The psychological implications of the interface between gynecological cancer and reproduction have to be taken into 
account in women’s health care. In order to do that, it is necessary to consider the complexity of this interface in three main 
areas: infertility, decision-making about childbirth and cancer diagnosis during pregnancy. It is acknowledged that each of 
these areas pose additional challenges to gynecologic cancer patients and their health care providers. As a result, research and 
practical developments in this area should try to structure and assess the efficacy of specialized psychological interventions 
that meet the demands of these patients. A multidisciplinary treatment approach is also essential, and the role of psychological 
teams is particularly important because these professionals may educate and foster useful skills in other health care providers. 
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